
Consider buying Summit Therapeutics (SMMT), as two co-CEOs each purchased $6 million worth of stock following a recent 27% price decline. Similarly, four top executives at Envestnet (ENV) are buying shares for the first time in over two years, suggesting they see value after a 30% drop in the last year. Conversely, the CEO of LSI Industries (LYTS) made his first-ever discretionary sale after a price pop, indicating a potential near-term top. The co-CEOs at Ichor Holdings (ICHR) are also making their first-ever sales after a large run-up, signaling the stock may be overvalued. Finally, heavy insider selling at LoanDepot (LDI) and Carvana (CVNA) suggests management is cashing out on recent price surges, raising caution about their current valuations.